Abstract
An alternative heterogeneously palladium catalysed procedure for the synthesis of functional stilbenes and bibenzyls is reported. Starting from aryl bromides and using simple commercially available Pd/C catalyst at a low catalytic rate (1 mol%), stilbenes are obtained with 30-100% GC-yields and bibenzyls are produced in a one-pot fashion with 27-100% GC-yields. The procedure showed, however, some limitations when applied to strongly deactivated aryl bromides that could be in some extent overcome by using corresponding iodo derivatives.
Keywords: Stilbene synthesis, bibenzyl synthesis, one-pot synthesis, heterogeneous palladium catalyst
Letters in Organic Chemistry
Title: Efficient Heterogeneously Palladium-Catalysed Synthesis of Stilbenes and Bibenzyls
Volume: 6 Issue: 1
Author(s): Giuseppe Cusati, Anja Wedig and Laurent Djakovitch
Affiliation:
Keywords: Stilbene synthesis, bibenzyl synthesis, one-pot synthesis, heterogeneous palladium catalyst
Abstract: An alternative heterogeneously palladium catalysed procedure for the synthesis of functional stilbenes and bibenzyls is reported. Starting from aryl bromides and using simple commercially available Pd/C catalyst at a low catalytic rate (1 mol%), stilbenes are obtained with 30-100% GC-yields and bibenzyls are produced in a one-pot fashion with 27-100% GC-yields. The procedure showed, however, some limitations when applied to strongly deactivated aryl bromides that could be in some extent overcome by using corresponding iodo derivatives.
Export Options
About this article
Cite this article as:
Cusati Giuseppe, Wedig Anja and Djakovitch Laurent, Efficient Heterogeneously Palladium-Catalysed Synthesis of Stilbenes and Bibenzyls, Letters in Organic Chemistry 2009; 6 (1) . https://dx.doi.org/10.2174/157017809787003043
DOI https://dx.doi.org/10.2174/157017809787003043 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotropic Role of HSF1 in Neoplastic Transformation
Current Cancer Drug Targets Asymmetric 1,3-Dipolar Cycloadditons of Stabilized Azomethine Ylides with Nitroalkenes
Current Topics in Medicinal Chemistry The Epigenetics of Breast Carcinogenesis and Metastasis
Current Genomics Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity
Current Pharmaceutical Design Synthesis and Biological Evaluation of the Salicylamide and Salicylic Acid Derivatives as Anti-Estrogen Agents
Medicinal Chemistry Estrogen: Roles in Spermatogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells
Letters in Drug Design & Discovery ACKNOWLEDGEMENTS TO REVIEWERS
Current Cancer Drug Targets Airway Inflammation and Airflow Limitation in COPD
Current Respiratory Medicine Reviews Chemoradiotherapy in Rectal Cancer
Current Drug Therapy Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry Subclinical Hypothyroidism and Homeostatic Disturbances: Case Report and Literature Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Novel Hybrid Molecules of Isoxazole Chalcone Derivatives: Synthesis and Study of in vitro Cytotoxic Activities
Letters in Drug Design & Discovery Herpesvirus Saimiri-Based Gene Delivery Vectors
Current Gene Therapy Ghrelin and Energy Balance: Focus on Current Controversies
Current Drug Targets Protein Biomarkers in Cancers of the Digestive Tract - a Step Towards Personalized Medicine
Current Proteomics Editorial (Thematic Issue: The Effects of Anticancer Agents on Cell Apoptosis and on the Expression of Cancer - Related Genes)
Anti-Cancer Agents in Medicinal Chemistry Is Cdc25 a Druggable Target?
Anti-Cancer Agents in Medicinal Chemistry Anti-Inflammatory/Analgesic
Current Bioactive Compounds The Chemical Basis of the Antinitrosating Action of Polyphenolic Cancer Chemopreventive Agents
Current Medicinal Chemistry